Gregory Scott Duncan

Insider Reports History

Entity
Individual
Location
44 Milton Avenue, Alpharetta, GA
Signature
/s/ Gregory Scott Duncan
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Gregory Scott Duncan:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Virios Therapeutics, Inc. CHIEF EXECUTIVE OFFICER, Director Common Stock 57.5K $74.9K $1.30 Aug 17, 2023 Direct
Virios Therapeutics, Inc. CHIEF EXECUTIVE OFFICER, Director Stock Option (right to buy) 139K Feb 26, 2024 Direct
CorMedix Inc. Director Stock Option (Right to Buy Common Stock) 30K Mar 5, 2024 Direct

Insider Reports Filed by Gregory Scott Duncan

Symbol Company Period Transactions Value $ Form Type Date Filed Role
CRMD CorMedix Inc. Mar 5, 2024 1 $0 4 Mar 20, 2024 Director
VIRI Virios Therapeutics, Inc. Feb 26, 2024 1 $0 4 Feb 28, 2024 CHIEF EXECUTIVE OFFICER, Director
VIRI Virios Therapeutics, Inc. Aug 17, 2023 1 $31.2K 4 Aug 18, 2023 CHIEF EXECUTIVE OFFICER, Director
CRMD CorMedix Inc. Jan 14, 2023 1 $0 4 Jan 18, 2023 Director
VIRI Virios Therapeutics, Inc. Dec 12, 2022 1 $0 4/A Feb 15, 2023 CHIEF EXECUTIVE OFFICER, Director
VIRI Virios Therapeutics, Inc. Jun 23, 2022 1 $0 4 Jun 30, 2022 CHIEF EXECUTIVE OFFICER, Director
VIRI Virios Therapeutics, Inc. May 23, 2022 1 $33.9K 4 May 24, 2022 CHIEF EXECUTIVE OFFICER, Director
CRMD CorMedix Inc. Feb 22, 2022 1 $0 4 Feb 23, 2022 Director
VIRI Virios Therapeutics, Inc. Dec 21, 2021 1 $27.6K 4 Dec 22, 2021 CHIEF EXECUTIVE OFFICER, Director
VIRI Virios Therapeutics, Inc. Jun 21, 2021 1 $0 4 Jun 22, 2021 CHIEF EXECUTIVE OFFICER, Director